NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 135 filers reported holding NEKTAR THERAPEUTICS in Q4 2013. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $624,000 | +145.7% | 26,599 | +28.3% | 0.02% | +183.3% |
| Q4 2016 | $254,000 | -40.2% | 20,729 | -16.2% | 0.01% | -40.0% |
| Q3 2016 | $425,000 | +11.5% | 24,723 | -7.5% | 0.01% | +25.0% |
| Q2 2016 | $381,000 | +95.4% | 26,741 | +130.7% | 0.01% | +166.7% |
| Q4 2015 | $195,000 | -18.8% | 11,593 | -39.6% | 0.00% | -25.0% |
| Q2 2015 | $240,000 | +71.4% | 19,207 | +51.3% | 0.00% | +33.3% |
| Q1 2015 | $140,000 | -68.0% | 12,692 | -65.0% | 0.00% | -62.5% |
| Q3 2014 | $437,000 | +30.1% | 36,234 | +38.2% | 0.01% | +60.0% |
| Q2 2014 | $336,000 | +116.8% | 26,214 | +105.4% | 0.01% | +150.0% |
| Q1 2014 | $155,000 | -61.6% | 12,762 | -67.0% | 0.00% | -60.0% |
| Q3 2013 | $404,000 | – | 38,717 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
| GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
| Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
| Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
| Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
| CM Management, LLC | 50,000 | $160,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
| PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
| Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
| ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |